Endometrial Cancer Trial, Recruiting NCT05793749 Sponsor: Chongqing University Cancer Hospital Condition: Endometrial Cancer
Back to Endometrial Cancer

Endometrial Cancer Trial, Recruiting

NCT05793749
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People with gynaecological cancer who are receiving radiotherapy after having lymph node surgery, and who agree to take part voluntarily by signing a consent form.
  • People aged between 18 and 60 years old.
  • People who are reasonably active and able to carry out daily activities, as measured by a standard medical performance scale (ECOG score below 2).
  • People whose doctors expect them to live for more than 3 years.
  • People whose blood test results fall within acceptable ranges, including healthy enough levels of red blood cells, white blood cells, and platelets (confirm specific values with the trial site).
  • People whose liver and kidney function blood test results are within acceptable ranges, and who have adequate protein levels in their blood (confirm specific values with the trial site).
  • People of childbearing potential who have had a negative pregnancy test within 7 days before joining, and who are willing to use a reliable form of contraception throughout the trial.
  • People who, in the opinion of the trial investigator, are able to follow the trial requirements.

Who may not be able to join:

  • People who have already been diagnosed with lymphoedema (fluid swelling from the lymphatic system) or deep vein thrombosis (blood clots in the leg veins).
  • People who currently have any kind of active infection.
  • People who have swelling in their lower legs or feet.
  • People who are pregnant or currently menstruating at the time of enrolment.
  • People who have recently had major abdominal surgery, as determined by the trial investigator.
  • People who have radiation-related bowel or bladder inflammation, intestinal infection, or pouches/inflammation in the large or small bowel.
  • People who have liver fibrosis (scarring of the liver).
  • People who have an abdominal aortic aneurysm (a bulge in the main blood vessel in the abdomen).
  • People who have acute phlebitis (sudden inflammation of a vein).
  • People who have severe blockages in their arteries, arterial ulcers, or certain abnormal blood pressure readings between the ankle and arm (confirm specific values with the trial site).
  • People who have severe nerve damage in their hands or feet.
  • People whose high blood pressure, history of stroke, diabetes, or severe asthma is not well controlled.
  • People who are unable to understand the trial content or are unwilling to cooperate, or who refuse to sign the consent form.
  • People who have other conditions or circumstances that, in the investigator's judgement, could seriously affect their safety or their ability to complete the trial.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 26 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: +8613657690699

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Chongqing University Cancer Hospital
Registry
ClinicalTrials.gov
Start date
1 April 2023
Est. completion
29 July 2026

Where this trial is recruiting

🇨🇳 China

Primary endpoints

Incidence of lymphedema; Quality of life of patients

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 26 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov